Shattuck Labs announces a poster presentation on SL-325 for inflammatory bowel disease at the 2025 Crohn’s and Colitis Congress. Shattuck Labs, Inc., a biotechnology company focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback